TP53 and cancer: First, cancer cells that express the p53 gene mutation are more resistant to CAP treatment than are cells that do not express this mutation [75]; second, cancer cells with higher proliferation rates are more sensitive to CAP treatment than are cells with lower proliferation rates [76].